We've found
184,457
clinical trials
We've found
184,457
clinical trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory Multiple Myeloma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory Multiple Myeloma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Profiling Biospecimens From Cancer Patients to Screen for Molecular Alterations Related to Treatment Selection
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Profiling Biospecimens From Cancer Patients to Screen for Molecular Alterations Related to Treatment Selection
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Profiling Biospecimens From Cancer Patients to Screen for Molecular Alterations Related to Treatment Selection
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Profiling Biospecimens From Cancer Patients to Screen for Molecular Alterations Related to Treatment Selection
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Profiling Biospecimens From Cancer Patients to Screen for Molecular Alterations Related to Treatment Selection
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Urothelial Carcinoma Clinical Trial
Updated: 12/31/1969
Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Moderate to Severe Crohn's Disease
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Ibrutinib and Lenalidomide in Treating Patients With Myelodysplastic Syndrome
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Phenylketonuria Clinical Trial
Updated: 11/30/2017
The Effectiveness of Kuvan in Amish PKU Patients
Status: Enrolling,
Phase
IV
Updated: 11/30/2017
Click here to add this to my saved trials

Neurology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Cognitive Behavior Therapy for Insomnia (CBT-I) in Persons With Traumatic Brain Injury (TBI)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Coronary Artery Disease Clinical Trial
Updated: 12/31/1969
Simultaneous Assessment of FFR and SPECT
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRT
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRT
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Arthroplasty, Replacement, Hip Clinical Trial
Updated: 12/31/1969
Trident II Tritanium Acetabular Shell Outcomes Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Renal Cell Carcinoma Clinical Trial
Updated: 12/31/1969
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Renal Cell Carcinoma Clinical Trial
Updated: 12/31/1969
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Renal Cell Carcinoma Clinical Trial
Updated: 12/31/1969
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Renal Cell Carcinoma Clinical Trial
Updated: 12/31/1969
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Renal Cell Carcinoma Clinical Trial
Updated: 12/31/1969
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Renal Cell Carcinoma Clinical Trial
Updated: 12/31/1969
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Myocardial Infarction Clinical Trial
Updated: 12/31/1969
Women's Heart Attack Research Program- Imaging Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Myocardial Infarction Clinical Trial
Updated: 12/31/1969
Women's Heart Attack Research Program- Imaging Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Myocardial Infarction Clinical Trial
Updated: 12/31/1969
Women's Heart Attack Research Program- Imaging Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Idiopathic Dilated Cardiomyopathy Clinical Trial
Updated: 12/31/1969
DCM Precision Medicine Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Idiopathic Dilated Cardiomyopathy Clinical Trial
Updated: 12/31/1969
DCM Precision Medicine Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Idiopathic Dilated Cardiomyopathy Clinical Trial
Updated: 12/31/1969
DCM Precision Medicine Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Idiopathic Dilated Cardiomyopathy Clinical Trial
Updated: 12/31/1969
DCM Precision Medicine Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Idiopathic Dilated Cardiomyopathy Clinical Trial
Updated: 12/31/1969
DCM Precision Medicine Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Idiopathic Dilated Cardiomyopathy Clinical Trial
Updated: 12/31/1969
DCM Precision Medicine Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Idiopathic Dilated Cardiomyopathy Clinical Trial
Updated: 12/31/1969
DCM Precision Medicine Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Idiopathic Dilated Cardiomyopathy Clinical Trial
Updated: 12/31/1969
DCM Precision Medicine Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Phase Chronic Myeloid Leukemia Clinical Trial
Updated: 12/31/1969
Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Phase Chronic Myeloid Leukemia Clinical Trial
Updated: 12/31/1969
Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Phase Chronic Myeloid Leukemia Clinical Trial
Updated: 12/31/1969
Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Phase Chronic Myeloid Leukemia Clinical Trial
Updated: 12/31/1969
Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Phase Chronic Myeloid Leukemia Clinical Trial
Updated: 12/31/1969
Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Phase Chronic Myeloid Leukemia Clinical Trial
Updated: 12/31/1969
Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Beta-Thalassemia Clinical Trial
Updated: 12/31/1969
A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Subjects With Transfusion-Dependent β-Thalassemia, Who Have a β0/β0 Genotype
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Schizophrenia Clinical Trial
Updated: 12/31/1969
This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Schizophrenia Clinical Trial
Updated: 12/31/1969
This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

AMD Clinical Trial
Updated: 12/31/1969
Generation of Induced Pluripotent Stem (iPS) Cell Lines From Skin Fibroblast Cells of Participants With Age-Related Macular Degeneration
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

AMD Clinical Trial
Updated: 12/31/1969
Generation of Induced Pluripotent Stem (iPS) Cell Lines From Skin Fibroblast Cells of Participants With Age-Related Macular Degeneration
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

AMD Clinical Trial
Updated: 12/31/1969
Generation of Induced Pluripotent Stem (iPS) Cell Lines From Skin Fibroblast Cells of Participants With Age-Related Macular Degeneration
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
